Chemistry Reference
In-Depth Information
[30] Abad-Zapatero, C., and Metz, T. (2005). Ligand efficiency indices as guideposts for drug
discovery.
Drug Discov. Today
10
, 464-469.
[31] Andrews, P. R., Craik, D. J., and Martin, J. L. (1984). Functional group contributions to
drug-receptor interactions.
J. Med. Chem
.
27
, 1648-1657.
[32] Kuntz, I. D., Chen, K., Sharp, K. A., and Kollman, P. A. (1999). The maximal affinity of ligands.
Proc. Natl. Acad. Sci
.
USA
96
, 9997-10002.
[33] Reynolds, C. H., Bembenek, S. D., and Tounge, B. A. (2007). The role of molecular size in
ligand efficiency.
Bioorg. Med. Chem. Lett
.
17
, 4258-4261.
[34] Oprea, T. I., Davis, A. M., Teague, S. J., and Leeson, P. D. (2001). Is there a difference between
leads and drugs? A historical perspective.
J. Chem. Inf. Comput. Sci
.
41
, 1308-1315.
[35] Hann, M. M., and Oprea, T. I. (2004). Pursuing the leadlikeness concept in pharmaceutical
research.
Curr. Opin. Chem. Biol
.
8
, 255-263.
[36] Stevens, R.C. (2004). Long live structural biology.
Nat. Struct. Mol. Biol
.
11
, 293-295.
